A prospective study of histocompatibility testing for keratoplasty in high-risk patients.
AUTOR(ES)
Ozdemir, O
RESUMO
Forty high-risk patients awaiting corneal grafting were randomly selected from a 7-year cumulative list. Twenty were grafted with HLA-A and HLA-B antigen matched material. The other 20 patients were used as controls. Graft survival at two years was 60% (12/20) in the control group and 90% (18/20) in the study group; at five years it was 55% (11/20) in the control group and 85% (17/20) in the study group.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1040963Documentos Relacionados
- Dilemma of high-tech care for high-risk patients.
- Cardiac monitoring of high‐risk patients after an electrical injury: a prospective multicentre study
- In utero myelomeningocele repair and high-risk bladder pattern. a prospective study
- Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients.
- ACE inhibitors and high-risk patients